Skip to main content
Fig. 5 | World Journal of Surgical Oncology

Fig. 5

From: Radiomic-based models are able to predict the pathologic response to different neoadjuvant chemotherapy regimens in patients with gastric and gastroesophageal cancer: a cohort study

Fig. 5

Performance of the predictive model for non-responders (TRG 4–5) to FLOT chemotherapy. Panel A (top left): ROC curve; Panel B (right): the y-axis represents the probability of being non-responders (TRG 4–5) predicted by the model for each patient – colors represent the true outcome, the dotted line represents the cut-off probability and classification threshold used to classify patients into non-responders and not non-responders, patients with predicted probability above the dotted line are predicted as non-responders (model-positives) and those with predicted probability below the line are predicted as not non-responders (model-negative); panel C (bottom left): calibration belt

Back to article page